Insider · CIK 0002024096

Otero Jose Manuel

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0002024096

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-24	LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+54.8K sh	—	—	54,750
2026-09-14	LXEOLexeo Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+2,110 sh	$2.64	+$5,578.84	138,288
2026-08-18	LXEOLexeo Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,304 sh	$4.96	−$6,464.058	136,178
2026-07-01	LXEOLexeo Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−4,666 sh	$4.48	−$20.9K	137,482
2026-06-29	LXEOLexeo Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+12.1K sh	—	—	142,148
2026-05-18	LXEOLexeo Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,302 sh	$5.07	−$6,606.348	130,088
2026-03-13	LXEOLexeo Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+5,930 sh	$2.64	+$15.7K	131,390
2026-02-18	LXEOLexeo Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,016 sh	$6.40	−$19.3K	125,460
2026-02-04	LXEOLexeo Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+65K sh	—	—	128,476
2026-02-04	LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+260K sh	—	—	260,000
2025-11-18	LXEOLexeo Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−721 sh	$9.27	−$6,683.67	63,476
2025-10-17	LXEOLexeo Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,091 sh	$8.94	−$18.7K	64,221
2025-10-17	LXEOLexeo Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−24 sh	$9.56	−$229.464	64,197
2025-10-15	LXEOLexeo Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+5,940 sh	—	—	66,312
2025-08-18	LXEOLexeo Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−721 sh	$9.27	−$6,683.67	63,476
2025-08-18	LXEOLexeo Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,848 sh	$4.67	−$13.3K	60,372
2025-03-14	LXEOLexeo Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+5,720 sh	$2.61	+$14.9K	63,220
2025-01-07	LXEOLexeo Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+26.3K sh	—	—	57,500
2025-01-07	LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+52.5K sh	—	—	52,500
2024-06-12	LXEOLexeo Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+31.3K sh	—	—	31,250
2024-06-12	LXEOLexeo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+188K sh	—	—	187,500

Recent filings

Accepted (ET)
Sep 284
Otero Jose Manuel0002024096-26-000015
SEC(opens sec.gov)
Aug 194
Otero Jose Manuel0002024096-26-000013
SEC(opens sec.gov)
Jul 14
Otero Jose Manuel0002024096-26-000011
SEC(opens sec.gov)
May 204
Otero Jose Manuel0002024096-26-000009
SEC(opens sec.gov)
Mar 174
Otero Jose Manuel0002024096-26-000007
SEC(opens sec.gov)
Feb 204
Otero Jose Manuel0002024096-26-000005
SEC(opens sec.gov)
Feb 204/A
Otero Jose Manuel0002024096-26-000004
SEC(opens sec.gov)
Feb 64
Otero Jose Manuel0002024096-26-000002
SEC(opens sec.gov)
Nov 204
Otero Jose Manuel0002024096-25-000005
SEC(opens sec.gov)
Oct 174
Otero Jose Manuel0002024096-25-000003
SEC(opens sec.gov)
Aug 204
Otero Jose Manuel0001415889-25-022479
SEC(opens sec.gov)
Apr 94
Otero Jose Manuel0001415889-25-010505
SEC(opens sec.gov)
Jan 104
Otero Jose Manuel0001415889-25-001286
SEC(opens sec.gov)
Jun 144
Otero Jose Manuel0000950170-24-073371
SEC(opens sec.gov)

Companies

Lexeo Therapeutics, Inc.Chief Operating OfficerLXEO

Address

C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, FLOOR 6

NEW YORK, NY, 10010